Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Nature Neuroscience
|
May 27, 2014
ALK5-dependent TGF-β signaling is a major determinant of late-stage adult neurogenesis
Yingbo He, Hui Zhang, Andrea Yung, et al.
The Journal of Clinical Investigation
|
May 24, 2008
The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice
Fiona Pickford, Eliezer Masliah, Markus Britschgi, et al.
Molecular Cell
|
April 23, 2016
Methylome-wide Analysis of Chronic HIV Infection Reveals Five-Year Increase in Biological Age and Epigenetic Targeting of HLA
Andrew M Gross, Philipp A Jaeger, Jason F Kreisberg, et al.
Journal of Medicinal Chemistry
|
July 15, 2024
Chasing Red Herrings: Palladium Metal Salt Impurities Feigning KRAS Activity in Biochemical Assays
Thomas Gerstberger, Helmut Berger, Frank H Büttner, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Combined KRAS<sup>G12C</sup> and SOS1 inhibition enhances and extends the anti-tumor response in KRAS<sup>G12C</sup>-driven cancers by addressing intrinsic and acquired resistance
Venu Thatikonda, Hengyu Lu, Sabine Jurado, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 2, 2013
TDP-43 frontotemporal lobar degeneration and autoimmune disease
Zachary A Miller, Katherine P Rankin, Neill R Graff-Radford, et al.
Molecular Neurodegeneration
|
May 25, 2016
Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain
Philipp A Jaeger, Kurt M Lucin, Markus Britschgi, et al.
Molecular Neurodegeneration
|
April 27, 2016
Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain
Philipp A Jaeger, Kurt M Lucin, Markus Britschgi, et al.
Nature Cancer
|
August 5, 2024
Co-targeting SOS1 enhances the antitumor effects of KRAS<sup>G12C</sup> inhibitors by addressing intrinsic and acquired resistance
Venu Thatikonda, Hengyu Lyu, Sabine Jurado, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Nature Neuroscience
|
May 27, 2014
ALK5-dependent TGF-β signaling is a major determinant of late-stage adult neurogenesis
Yingbo He, Hui Zhang, Andrea Yung, et al.
The Journal of Clinical Investigation
|
May 24, 2008
The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice
Fiona Pickford, Eliezer Masliah, Markus Britschgi, et al.
Molecular Cell
|
April 23, 2016
Methylome-wide Analysis of Chronic HIV Infection Reveals Five-Year Increase in Biological Age and Epigenetic Targeting of HLA
Andrew M Gross, Philipp A Jaeger, Jason F Kreisberg, et al.
Journal of Medicinal Chemistry
|
July 15, 2024
Chasing Red Herrings: Palladium Metal Salt Impurities Feigning KRAS Activity in Biochemical Assays
Thomas Gerstberger, Helmut Berger, Frank H Büttner, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Combined KRAS<sup>G12C</sup> and SOS1 inhibition enhances and extends the anti-tumor response in KRAS<sup>G12C</sup>-driven cancers by addressing intrinsic and acquired resistance
Venu Thatikonda, Hengyu Lu, Sabine Jurado, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 2, 2013
TDP-43 frontotemporal lobar degeneration and autoimmune disease
Zachary A Miller, Katherine P Rankin, Neill R Graff-Radford, et al.
Molecular Neurodegeneration
|
May 25, 2016
Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain
Philipp A Jaeger, Kurt M Lucin, Markus Britschgi, et al.
Molecular Neurodegeneration
|
April 27, 2016
Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain
Philipp A Jaeger, Kurt M Lucin, Markus Britschgi, et al.
Nature Cancer
|
August 5, 2024
Co-targeting SOS1 enhances the antitumor effects of KRAS<sup>G12C</sup> inhibitors by addressing intrinsic and acquired resistance
Venu Thatikonda, Hengyu Lyu, Sabine Jurado, et al.
Page
of 2